995 related articles for article (PubMed ID: 9547351)
1. Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells.
Sulentic CE; Holsapple MP; Kaminski NE
Mol Pharmacol; 1998 Apr; 53(4):623-9. PubMed ID: 9547351
[TBL] [Abstract][Full Text] [Related]
2. Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells.
Suh J; Jeon YJ; Kim HM; Kang JS; Kaminski NE; Yang KH
Toxicol Appl Pharmacol; 2002 Jun; 181(2):116-23. PubMed ID: 12051995
[TBL] [Abstract][Full Text] [Related]
3. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway.
Sulentic CE; Holsapple MP; Kaminski NE
J Pharmacol Exp Ther; 2000 Nov; 295(2):705-16. PubMed ID: 11046109
[TBL] [Abstract][Full Text] [Related]
4. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation of Pax5 in lipopolysaccharide-activated B cells.
Yoo BS; Boverhof DR; Shnaider D; Crawford RB; Zacharewski TR; Kaminski NE
Toxicol Sci; 2004 Feb; 77(2):272-9. PubMed ID: 14600275
[TBL] [Abstract][Full Text] [Related]
5. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces plasminogen activator inhibitor-1 through an aryl hydrocarbon receptor-mediated pathway in mouse hepatoma cell lines.
Son DS; Rozman KK
Arch Toxicol; 2002 Jul; 76(7):404-13. PubMed ID: 12111005
[TBL] [Abstract][Full Text] [Related]
6. Involvement of Blimp-1 and AP-1 dysregulation in the 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated suppression of the IgM response by B cells.
Schneider D; Manzan MA; Yoo BS; Crawford RB; Kaminski N
Toxicol Sci; 2009 Apr; 108(2):377-88. PubMed ID: 19237549
[TBL] [Abstract][Full Text] [Related]
7. Responsiveness of the adult male rat reproductive tract to 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure: Ah receptor and ARNT expression, CYP1A1 induction, and Ah receptor down-regulation.
Roman BL; Pollenz RS; Peterson RE
Toxicol Appl Pharmacol; 1998 Jun; 150(2):228-39. PubMed ID: 9653054
[TBL] [Abstract][Full Text] [Related]
8. Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6.
Phadnis-Moghe AS; Crawford RB; Kaminski NE
Toxicol Sci; 2015 Mar; 144(1):39-50. PubMed ID: 25543051
[TBL] [Abstract][Full Text] [Related]
9. Functional activation of arylhydrocarbon receptor (AhR) in primary T cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Doi H; Baba T; Tohyama C; Nohara K
Chemosphere; 2003 Jul; 52(4):655-62. PubMed ID: 12738279
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide activation of murine splenocytes and splenic B cells increased the expression of aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator.
Marcus RS; Holsapple MP; Kaminski NE
J Pharmacol Exp Ther; 1998 Dec; 287(3):1113-8. PubMed ID: 9864300
[TBL] [Abstract][Full Text] [Related]
11. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces suppressor of cytokine signaling 2 in murine B cells.
Boverhof DR; Tam E; Harney AS; Crawford RB; Kaminski NE; Zacharewski TR
Mol Pharmacol; 2004 Dec; 66(6):1662-70. PubMed ID: 15371557
[TBL] [Abstract][Full Text] [Related]
12. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation and posttranslational modification of p27kip1 in lipopolysaccharide-activated B cells.
Crawford RB; Sulentic CE; Yoo BS; Kaminski NE
Toxicol Sci; 2003 Oct; 75(2):333-42. PubMed ID: 12883080
[TBL] [Abstract][Full Text] [Related]
13. An integrated genomic analysis of aryl hydrocarbon receptor-mediated inhibition of B-cell differentiation.
De Abrew KN; Kaminski NE; Thomas RS
Toxicol Sci; 2010 Dec; 118(2):454-69. PubMed ID: 20819909
[TBL] [Abstract][Full Text] [Related]
14. Leukocyte activation induces aryl hydrocarbon receptor up-regulation, DNA binding, and increased Cyp1a1 expression in the absence of exogenous ligand.
Crawford RB; Holsapple MP; Kaminski NE
Mol Pharmacol; 1997 Dec; 52(6):921-7. PubMed ID: 9415701
[TBL] [Abstract][Full Text] [Related]
15. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated impairment of B cell differentiation involves dysregulation of paired box 5 (Pax5) isoform, Pax5a.
Schneider D; Manzan MA; Crawford RB; Chen W; Kaminski NE
J Pharmacol Exp Ther; 2008 Aug; 326(2):463-74. PubMed ID: 18483191
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of aryl hydrocarbon receptor-dependent induction of CYP1A1 and inhibition of IgM expression by di-ortho-substituted polychlorinated biphenyls.
Suh J; Kang JS; Yang KH; Kaminski NE
Toxicol Appl Pharmacol; 2003 Feb; 187(1):11-21. PubMed ID: 12628580
[TBL] [Abstract][Full Text] [Related]
17. Aryl hydrocarbon receptor expression and activity in cerebellar granule neuroblasts: implications for development and dioxin neurotoxicity.
Williamson MA; Gasiewicz TA; Opanashuk LA
Toxicol Sci; 2005 Feb; 83(2):340-8. PubMed ID: 15537747
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the aryl hydrocarbon receptor complex in human B lymphocytes: evidence for a distinct nuclear DNA-binding form.
Masten SA; Shiverick KT
Arch Biochem Biophys; 1996 Dec; 336(2):297-308. PubMed ID: 8954578
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the Cyp2a5 gene involves an aryl hydrocarbon receptor-dependent pathway.
Arpiainen S; Raffalli-Mathieu F; Lang MA; Pelkonen O; Hakkola J
Mol Pharmacol; 2005 Apr; 67(4):1325-33. PubMed ID: 15657367
[TBL] [Abstract][Full Text] [Related]
20. Role of aryl hydrocarbon receptor polymorphisms on TCDD-mediated CYP1B1 induction and IgM suppression by human B cells.
Kovalova N; Manzan M; Crawford R; Kaminski N
Toxicol Appl Pharmacol; 2016 Oct; 309():15-23. PubMed ID: 27535091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]